WYOST 120 mg/ 1.7 ml sol inj 120 mg 1 pce
7680699440016
Pharmacode 1153513
CH-69944
M05BX04
07.16.1.
Active substances:
1 / 3
google
Details
- GTIN
- 7680699440016
- Pharmacode
- 1153513
- Product number
- 6994401
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- denosumabum 120 mg, sorbitolum 78.9 mg, acidum aceticum glaciale, polysorbatum 20, natrii hydroxidum aut acidum hydrochloridum concentratum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 1.7 ml corresp. natrium 0.5 mg.
Articles (1)
Wyost 120 mg/ 1.7 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
denosumabum
|
120.0 MG | Substance | Wirkstoff (Principe actif) |
|
sorbitolum
|
78.9 MG | Substance | HBESI |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
polysorbatum 20
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
acidum hydrochloridum concentratum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.5 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 210.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2026
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69944
- Drug name
- Wyost, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- M05BX04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 24/01/2025
- Authorization expiration date
- 23/01/2030
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- WYOST 120 mg/ 1.7 ml sol inj 120 mg 1 pce
- Description (DE)
- WYOST 120 mg/ 1.7 ml Inj Lös 120 mg 1 Stk
- Market launch
- 01/02/2026
- Narcotic (BTM)
- No